Search Results - "Reiermann, S"

Quality of Life, Coping, and Mental Health Status After Living Kidney Donation by Wiedebusch, S, Reiermann, S, Steinke, C, Muthny, F.A, Pavenstaedt, H.J, Schoene-Seifert, B, Senninger, N, Suwelack, B, Buyx, A.M

“…Abstract The main aim of the study was to explore well-being after donation. This retrospective, cross-sectional study of 161 living kidney donors (104 women;…”
Get full text

HIGH PREVALENCE OF BK-VIREMIA AND BK-VIRUS NEPHROPATHY AND PROGNOSTIC FACTORS IN CAUCASIAN RENAL TRANSPLANT RECIPIENTS: 2164 by Malyar, V., Busch, V., Hillebrand, U., Reiermann, S., Kliche, K., Breil, B., Dugas, M., Suwelack, B.

Get full text

INFLUENCE OF ERYTHROPOIETIN ON VASCULAR FUNCTION IN RENAL TRANSPLANT RECIPIENTS: 4D.05 by Bartels, V., Hillebrand, U., Reiermann, S., Kosch, M., Kisters, K., Lang, D., Di Marco, G., Pavenstädt, H., Hausberg, M.

Get full text

INFLUENCE OF ESA THERAPY ON ENDOTHELIAL FUNCTION AND PULSE WAVE VELOCITY IN RENAL TRANSPLANT RECIPIENTS: PP.9.382 by Reiermann, S, Kliche, K, Bartels, V, Trappe, L, Malyar, V, Hillebrand, U, Suwelack, B, Kisters, K, Pavenstädt, H, Hausberg, M

Get full text

IF/TA-related metabolic changes—proteome analysis of rat renal allografts by Reuter, Stefan, Reiermann, Stefanie, Wörner, Reka, Schröter, Rita, Edemir, Bayram, Buck, Fritz, Henning, Stefanie, Peter-Katalinic, Jasna, Vollenbröker, Beate, Amann, Kerstin, Pavenstädt, Hermann, Schlatter, Eberhard, Gabriëls, Gert

“…Background. Chronic allograft nephropathy, now more specifically termed interstitial fibrosis and tubular atrophy without evidence of any specific aetiology…”
Get full text

Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patients by Kreusser, Wilhelm, Reiermann, Stefanie, Vogelbusch, Gert, Bartual, Josè, Schulze-Lohoff, Eckhard

“…A number of studies suggested that the type of dialysis membrane is associated with differences in long-term outcome of patients undergoing haemodialysis, both…”
Get full text

Опыт ведения пациентов с болезнью Фабри после изменения дозы или смены препарата в процессе проведения ферментозаместительной терапии by Weidemann, F, Krämer, J, Duning, T, Lenders, M, Canaan-Kühl, S, Krebs, A, González, H G, Sommer, C, Üçeyler, N, Niemann, M, Störk, S, Schelleckes, M, Reiermann, S, Stypmann, J, Brand, S M, Wanner, C, Brand, E, González, H, Brand, S M

“…В связи с перебоями в поставках агалсидазы бета в 2009 г. многие пациенты с болезнью Фабри (БФ) были переведены на терапию меньшими дозами этого фермента или…”
Get full text

A new tool for job evaluation by Reiermann, S

Get more information